Skip to main content
. 2021 Jan 14;13(2):282. doi: 10.3390/cancers13020282

Figure 8.

Figure 8

Tumor kinetics and survival data from mice treated with 200 μg of IC blocking antibody. Mice were treated every third day for a total of three doses (q3dx3). (A) The tumor growth curves show a decreased tumor growth for anti PD-L1 and anti PD-L1 + anti LAG-3. (B) The Kaplan–Meier curve shows a significant survival benefit for anti PD-L1 and anti PD-L1 + anti LAG-3. Error bars represent the standard deviation, n = 18, pooled data from three independent experiments, * p < 0.05, ** p < 0.01: statistically significant difference in survival.